Biote Acquires Asteria Health for $8.5M, Names New CFO

by | Jan 24, 2024
"This strategic transaction expands and strengthens Biote’s capabilities by enabling the vertical integration of our manufacturing and providing direct control over our pharmacokinetic research efforts," Biote CEO Terry Weber said. Earlier this month, Robert Peterson was named as Biote's new CFO.